Skip to content
  • Thursday, 20 August 2026
  • 12:01 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Neuroscience & Brain Research

Challenges to the Centaur Model Highlight Persistent Gaps Between Artificial Intelligence and Human Cognitive Processes

Rifan Muazin May 7, 2026 0

The pursuit of a unified theory of the human mind has remained one of the most elusive goals in the…

Read More
Biotech & Genetic Research

AACR 2026 Annual Meeting in San Diego to Highlight Precision Oncology and Integrated Therapies Under Co-Chairs Alice Shaw and Paul Mischel

Jia Lissa Apr 15, 2026 0

The global scientific community is counting down the days until the highly anticipated 2026 annual meeting of the American Association…

Read More
Molecular & Cell Biology

Antibiotic Residues Found in Piracicaba River and Local Fish Highlight Environmental and Health Risks

Angie Faith Mar 22, 2026 0

Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have identified multiple classes…

Read More
Molecular Switch Discovery Offers Path to Enhanced Blood Stem Cell Regeneration and Improved Bone Marrow TransplantsBreakthrough Study Reveals Synergistic Drug Combination to Overcome Differentiation Blockade in Acute Myelogenous LeukemiaScientists Solve the Two-Century-Old Dolomite Problem by Unlocking the Secret of Pulsed Crystal GrowthEli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic Therapeutics
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ